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Abstract
In this paper, we investigated the role of sorting nexin 12 (SNX12) in the endocytic pathway. SNX12 is a member of the PX
domain-containing sorting nexin family and shares high homology with SNX3, which plays a central role in the formation of
intralumenal vesicles within multivesicular endosomes. We found that SNX12 is expressed at very low levels compared to
SNX3. SNX12 is primarily associated with early endosomes and this endosomal localization depends on the binding to 3-
phosphoinositides. We find that overexpression of SNX12 prevents the detachment (or maturation) of multivesicular
endosomes from early endosomes. This in turn inhibits the degradative pathway from early to late endosomes/lysosomes,
much like SNX3 overexpression, without affecting endocytosis, recycling and retrograde transport. In addition, while
previous studies showed that Hrs knockdown prevents EGF receptor sorting into multivesicular endosomes, we find that
overexpression of SNX12 restores the sorting process in an Hrs knockdown background. Altogether, our data show that
despite lower expression level, SNX12 shares redundant functions with SNX3 in the biogenesis of multivesicular endosomes.
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Introduction
Endocytosis is a process by which solutes, growth factors as well
as plasma membrane proteins and lipids are internalized into the
cell, through clathrin-coated vesicles and clathrin-independent
pathways [1]. After reaching early endosomes, molecules are
efficiently sorted into different routes. Some molecules including
the transferrin receptor are recycled back to the plasma membrane
to be reused, while others are routed towards the Golgi complex.
Ubiquitinated signaling receptors, including the EGF receptor
(EGFR), are targeted to the degradative pathway. In this process,
EGFR is sorted into the intralumenal vesicles that form in
multivesicular regions of early endosomes via Hrs and ESCRT
complexes [2]. The multivesicular regions then detach – or
mature – from early endosomes and become multivesicular
endosomes, referred to as endosomal carrier vesicles or multive-
sicular bodies (ECV/MVBs) [3,4], which function as transport
intermediates towards late endosomes. Eventually, intralumenal
vesicles and their protein cargo are delivered to lysosomes where
degradation occurs.
Sorting nexins (SNX) belong to a family of proteins, which all
share a PX domain that binds 3-phosphorylated inositides, thus
allowing selective membrane association primarily to endosomes
[5,6] [7]. Beyond this single common characteristic, SNX proteins
are involved in various membrane-related processes in the
endocytic pathway, and they may contain one or more additional
structural motifs with very diverse functions, including protein-
protein or protein-lipid interactions, or enzymatic activities [7]. In
particular, some SNX family members contain, in addition to the
PX domain, a BAR domain, which interacts with membrane lipids
and functions as a curvature sensor [6,8]. This group includes
SNX1, SNX2, SNX5 and SNX6, which are components of the
retromer complex involved in endosome-to-Golgi transport [9],
and SNX4, which regulates transferrin receptor sorting [10]. The
PX-BAR group also includes SNX9, which contains an SH3
domain in addition to the BAR domain and which couples actin
dynamics and endocytic membrane remodeling [11,12], SNX18,
an SNX9 paralog, involved in AP1-membrane tubulation [13],
and SNX33, which plays a role in actin polymerization via
interactions with WASP [14]. In addition, SNX13 and SNX25,
which share two putative trans-membrane domains and a RGS
(regulator of G-protein signaling) domain [7], play a role in mouse
development and endocytosis [15] and TGFbeta signaling [16],
respectively. Moreover, SNX15, which includes a MIT (microtu-
bule interacting and trafficking molecule) domain is involved in
endosome morphology and trafficking [17], while SNX16, which
also contains a structural domain with unknown functions, plays a
role in EGF receptor trafficking [18] and dynamics of late
endosome tubulo-cisternal membranes [19]. Finally, both SNX17
and SNX27 share a C-terminal FERM domain, with SNX17
being involved in LRP recycling [20], and SNX27 in PDZ-
directed sorting from endosomes to the plasma membrane [21].
SNX3 belongs to the sub-group of the SNX proteins that
contain only a PX domain and no other structural motifs [7]. In
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complementary, functions in the endosomal system. In yeast, the
SNX3 homolog Grd19p is involved in the selective retrieval of
some membrane proteins from the pre-vacuolar compartment,
presumably late endosomes, to the TGN [22,23]. Similarly, SNX3
was proposed to be part of an alternative retromer pathway
involved in the very specific retrograde transport of Wnt-binding
protein Wntless but not other retromer cargo [24], consistent with
observations that endosome-to-Golgi transport of Shiga toxin B-
subunit does not seem to depend on SNX3 [25], but SNX1 [26].
Evidence also showed that SNX3 is involved in the maturation of
the Salmonella-containing vacuole in infected cells [27]. Finally,
we had previously reported that SNX3 plays a role in ECV/MVB
biogenesis, and controls the formation of intralumenal vesicles that
contain EGFR [25]. SNX12 shares the highest homology among
the SNX family with SNX3, but nothing is known about its
function. In this paper, we investigated the role of SNX12, and
report that protein acts as a functional homolog of SNX3 in ECV/
MVB biogenesis.
Results and Discussion
SNX12 Localizes to Early Endosomes
SNX12 (NCBI Reference Sequence: NM_013346.2) is a
member of the sorting nexin protein family, which apparently
contains a PX domain as sole structural domain. The protein
consists of 162 amino acids with a predicted molecular weight of
,20 kDa. Alignment reveals that SNX12 and SNX3, which is
also a PX-only protein, share the highest identity amongst SNX
family members, with 70.8% DNA identity and 79.5% protein
identity (Figure 1A). Since we previously studied the role of SNX3
in protein sorting and membrane transport, we investigated
whether SNX12 could also share the same functions as SNX3. To
this end, we first quantified by quantitative PCR the relative
amount of SNX12 and SNX3 transcripts in different cell lines such
as HeLa, HepG2, Caco-2 and PC-3 cells. We found that in these
cell lines, SNX12 is expressed at very low levels when compared to
SNX3 (<100–200 fold less) (Figure 1B). This is in good agreement
with an exhaustive analysis of the transcription profiles of SNX3
and SNX12 in tissues and cell lines carried out with Genevesti-
gator (https://www.genevestigator.com/gv/index.jsp), which
combines thousands of microarray experiments. Interestingly,
SNX3 and SNX12 genes are highly conserved in vertebrates.
However, only one common ancestor gene is found in insects (D.
melanogaster) and yeast (S. cerevisiae), suggesting a gene
duplication during evolution. In human, it is important to note
that SNX3 gene is located on chromosome 6 (position 6q21)
whereas SNX12 gene is located on chromosome X (location
Xq13.1). It is thus possible that the expression of the SNX12 gene
on sex chromosome is more tightly regulated than that of SNX3
on an autosomal chromosome.
Because of its low abundance and similarity to SNX3, it is not
easy to analyze the distribution of endogenous SNX12. We thus
tagged SNX12 with GFP and expressed the construct in HeLa
cells. Like most PtdIns3P-binding proteins that have been studied,
GFP-SNX12 was primarily associated with early endosomes and
colocalized with both EEA1 and SNX3, but not with the late
endosomal marker LBPA (Figure 1C). Moreover, and as
previously described for SNX3 and other PtdIns3P-binding
proteins, the endosomal localization of SNX12 was dependent
on the binding to 3-phosphoinositides since treatment with
wortmannin, a pan-inhibitor of PI 3-Kinases, induced the release
of SNX12 in the cytoplasm (Figure S2A). Release was not
complete presumably because the proteins remained in part
associated to membranes via protein-protein interactions. To
analyse more precisely the role of the PX domain in membrane
association, we mutated the highly conserved arginine 71 of the
PX domain of SNX12 to alanine. The protein was incubated with
PtdIns3P-containing liposomes, and then the mixture was loaded
at the bottom of a step sucrose gradient and liposomes were
retrieved by floatation. We observed that the SNX12
R71A mutant
had lost the capacity to bind PtdIns3P-containing liposomes, when
compared to wild type SNX12 (Figure S2B-C). Consistently, the
PtdIns3P binding-defective mutant SNX12
R71A, was no longer
membrane-associated (Figure S2A), much like SNX3
R70A mutant
[25], consistent with the notion that membrane targeting requires
PtdIns3P-binding.
A recent study showed that SNX3 interacts with the retromer
and is involved in the highly selective retrograde transport of the
Wnt sorting receptor Wntless [24]. We thus investigated whether
SNX12 may also be linked to the retromer components. We
observed by immunofluorescence that mRFP1-SNX12 co-localiz-
es with the retromer subunits Vps35 and Vps26 on endosomes
(Figure S3A). We then investigated whether SNX12 interacts with
the retromer using GST pull down assays. After incubating cell
lysates with recombinant SNX1, SNX3 or SNX12, we found that,
as expected, SNX1 and SNX3 binds to Vps35. Interestingly,
SNX12 is also associated with Vps35, demonstrating that SNX12
shares with SNX3 the capacity to interact with retromer
components (Figure S3B-C).
Excess SNX12 Inhibits Transport Beyond Early
Endosomes
Previously we had observed that excess SNX3 inhibited
membrane transport beyond early endosomes. We then tested
whether SNX12 overexpression caused a similar inhibition. When
overexpressed, SNX12 did not affect EGF internalization since
endocytosed EGF
AlexaFluor488 colocalized with EEA1-positive early
endosomes after 10 min pulse (Figure 2A) much like in control
cells (Figure S1A). However, and in contrast to control cells (Figure
S1B-C), EGF was not transported to Lamp1-positive late
endosomes (Figure 2C) but still remained in early endosomes
(Figure 2B) after 50 min in cells expressing SNX12. Consistent
with these observations, overexpressed Myc-SNX12 inhibited
EGFR degradation in the presence of EGF to the same extent as
myc-SNX3, at comparable levels of expression (Figure 2D). By
contrast, the PtdIns3P binding-defective mutant SNX12
R71A did
not affect EGFR degradation (Figure S2D). This demonstrates
that SNX12
R71A mutant, which is not able to bind PtdIns3P,
having lost the capacity to localize to endosomes, cannot interfere
EGFR transport and degradation.
Having observed that overexpressed SNX12 inhibited transport
towards late endosomes and lysosomes, we investigated whether all
export routes from early endosomes were also affected. Shiga toxin
B-subunit navigates retrogradely, from the plasma membrane via
early/recycling endosomes, to the Golgi apparatus and eventually
to the endoplasmic reticulum. Shiga toxin B-subunit reached
transferrin receptor-positive early endosomes after 10 min incu-
bation at 37uC and was then exported to the Golgi complex
containing Rab6 after 50 min in cells expressing SNX12
(Figure 2E) as well as in control cells (Figure S1D). This
demonstrates that Shiga toxin B-subunit retrograde transport
from early endosomes to the Golgi apparatus is not affected by
excess SNX12.
Similarly, binding of fluorescent transferrin to its receptor on
the cell surface was much the same as in cells overexpressing GFP-
SNX12 and control cells (Figure 2F), indicating that receptor
cycling was most likely not affected by overexpression. Upon
SNX12 in Transport
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was efficiently internalized in cells overexpressing GFP-SNX12 as
in control cells (Figure 2F), further demonstrating that endocytosis
was not affected. When cells were incubated at 37uC for longer
time periods, no transferrin could be detected intracellularly
whether SNX12 was overexpressed or not (Figure 2F), demon-
strating that transferrin receptor recycling was not affected by
excess SNX12.
It thus appears that SNX12 overexpression specifically blocks
the degradative pathway from early to late endosomes/lysosomes,
without affecting endocytosis, recycling from early endosomes to
the plasma membrane and retrograde transport from early
endosomes to the Golgi apparatus.
Infection with Vesicular Stomatitis Virus
During vesicular stomatitis virus (VSV) infection, the envelope
of endocytosed virions undergoes low pH-mediated fusion with
endosomal membranes. We had observed that VSV fusion occurs
primarily with internal vesicles of ECV/MVBs, thereby releasing
the viral nucleocapsids into the lumen of internal vesicles [28,29].
These internal vesicles are then delivered to late endosomes, where
their back-fusion with the limiting membrane releases the viral
RNA into the cytosol, allowing synthesis of viral proteins to
proceed. Typically, viral infection is sensitive to conditions that
affect transport to late endosomes or late endosome dynamics,
including microtubule depolymerization [28,29] (Figure 3B-C). By
contrast, in SNX3-depleted cells, microtubule depolymerization
no longer inhibits viral infection, presumably because the viral
RNA is released from an earlier endosome in the pathway [25].
However, after SNX12 depletion (Figure 3A-C), VSV infection
remained sensitive to microtubule depolymerization much like in
mock-treated cells (Figure 3C, quantification in 3B).
These observations may indicate that SNX12 and SNX3
exhibit different functions. Alternatively, SNX12 and SNX3 may
exhibit similar functions, but SNX12 depletion may have little
impact given the low levels of its transcript when compared to
SNX3 (Figure 1B). Similarly, SNX12 depletion did not affect the
transport of EGFR from early-to-late endosomes (Figure 3D) and
the degradation of EGFR after continuous EGF stimulation
(Figure 3E).
Ultrastructure of Early Endosomes
Since SNX12 overexpression inhibited transport beyond early
endosomes towards late endosomes and lysosomes, we analyzed
Figure 1. SNX12 is less expressed than SNX3 but is also localized on early endosomes. (A) Alignment of amino acid sequences of Homo
sapiens SNX3 and SNX12. (B) RNA was extracted from different cell lines as indicated and relative amounts of endogenous SNX3 and SNX12 mRNA
were quantified by RT-PCR. Values are indicated in the table below the graph since they are very low for SNX12 mRNA. (C) HeLa cells expressing GFP-
SNX12 or co-expressing GFP-SNX12 and mRFP1-SNX3 were processed for immunofluorescence using the indicated antibodies. Scale bar indicates
10 mm.
doi:10.1371/journal.pone.0038949.g001
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By electron microscopy, clusters containing several multivesic-
ular endosomes were typically observed in cells overexpressing
SNX12 (Figure 4A), like SNX3 [25], while such clusters were
not observed in control cells (not shown) [3]. Each individual
multivesicular element, however, resembled ECV/MVBs, which
function as transport intermediates between early and late
endosomes. Immunogold labeling showed that the limiting
membrane of these structures was decorated with GFP-
SNX12, particularly in electron-dense flat regions of the limiting
membrane (Figure 4B) resembling the endosomal clathrin coat
involved in sorting ubiquitinated proteins into intralumenal
vesicles of early endosomes [30,31]. Since SNX12 is primarily
located on early endosomes (Figure 1), these ECV-MVB-like
structures presumably correspond to the vesicular regions of
early endosomes that cannot detach or mature from early
endosomes anymore, perhaps because SNX12 accumulation
interferes with coat disassembly.
Altogether, these results suggest that overexpressed SNX12,
much like overexpressed SNX3 [25], prevents the detachment of
ECV/MVBs, without interfering with the formation of intralu-
menal vesicles, thereby inhibiting early-to-late endosome trans-
port.
Sorting of EGFR into the Multivesicular Endosome
In our previous studies, we had found that SNX3 depletion
interferes with viral infection because the formation of
intralumenal vesicles in ECV/MVBs is inhibited [25]. In these
cells, VSV undergoes low pH-fusion with the limiting
membrane, since ECV/MVBs are devoid of intralumenal
Figure 2. SNX12 overexpression inhibits EGFR transport and degradation without affecting retrograde and recycling transport
routes. (A-C) After cell surface binding, EGF-biotin coupled to streptavidin
AlexaFluor488 was endocytosed for 10 min (A) or 50 min (B-C)a t3 7 uCi n
HeLa cells expressing mRFP1-SNX12. Cells were labeled with anti-EEA1 (A) or Lamp1 (B-C) antibodies and analyzed by triple channel fluorescence.
(D) HeLa cells expressing myc-SNX12 or myc-SNX3 or mock-treated were incubated with EGF for the indicated time periods. Cell lysates (100 mg)
were analyzed by SDS gel electrophoresis and western blotting with antibodies against EGFR, a-tubulin (a-tub) or myc. (E) After cell surface binding,
Shiga toxin B-subunit conjugated to Cy3 was internalized for 10 min or 50 min at 37uC into HeLa cells expressing GFP-SNX12. Cells were labeled with
anti-transferrin receptor (TfR) or Rab6 antibodies and analyzed by triple channel fluorescence. (F) After cell surface binding (0 min), transferrin
conjugated to AlexaFluor546 (transferrin
546) was internalized for 30 min or 120 min at 37uC into control cells (upper panels) or cells expressing GFP-
SNX12 (lower panels). Cells were then analyzed by fluorescence. (A-C and E-F) Scale bar indicates 10 mm.
doi:10.1371/journal.pone.0038949.g002
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for microtubule-dependent transport towards late endosomes.
Consistent with this view, we had also found that SNX3
depletion inhibits EGFR sorting into empty ‘‘multivesicular’’
endosomes [25], as expected. It had been shown that Hrs
depletion also inhibits intralumenal vesicle formation, presum-
ably because Hrs is necessary to recruit ESCRTs and other
factors [31,32,33]. We found that, in an Hrs knockdown
background, SNX3 restores both intralumenal vesicle formation
and EGFR sorting into multivesicular endosomes [25].
To determine whether SNX12 could fulfill the same role as
SNX3, we investigated whether SNX12 could also restore EGFR
sorting into multivescular endosomes after Hrs knockdown. To
this end, we used the Rab5
Q79L GTPase-deficient mutant of Rab5
to trigger the formation of enlarged endosomes [25,31,34] with
sufficient spatial resolution for light microscopy analysis
(Figure 4D-G, quantification in Figure 4C). As expected, EGFR
remained on the limiting membrane of these enlarged endosomes
after Hrs or SNX3 depletion (Figure 4D-F, quantification in
Figure 4C), presumably because they lacked intralumenal mem-
branes. By contrast, overexpression of SNX12 in the Hrs or SNX3
knockdown background restored the appearance of EGFR in the
lumen of enlarged endosomes (Figure 4E-G, quantification in
Figure 4C), as did SNX3 [25]. Altogether these results indicate
that SNX12 can fulfill the same functions as SNX3 in endosomal
membrane transport.
Materials and Methods
Cells, Antibodies and Reagents
The maintenance of HeLa, HepG2, Caco-2 and PC-3 cells was
as described [3,35,36]. We used the following mouse monoclonal
antibodies against: GFP (Roche Diagnostics); transferrin receptor
(Zymed Laboratories. South San Francisco, CA); EEA1 (Trans-
duction Laboratories); LAMP1 (CD107a; BD Biosciences); EGFR
Figure 3. SNX12 silencing has no effect on VSV infection and EGFR transport and degradation. (A) HeLa cells treated with siRNAs against
SNX12 or mock-treated were lysed. Lysates were analyzed by SDS gel electrophoresis and western blotting using with antibodies against myc, SNX3
or actin. (B-C) HeLa cells were treated with SNX12 siRNAs or mock-treated, and then microtubules were depolymerized or not with 10 mM
nocodazole for 2 h. VSV (1 MOI) was bound at 4uC at the cell surface and cells were then incubated for 3 h at 37uC to allow VSV infection to proceed.
Cells were analyzed by immunofluorescence with antibodies against VSV-G protein. Scale bar indicates 10 mm. Experiments were quantified (B) and
representative pictures were shown in (C). Under these conditions <50% of the control cells were infected so that changes in infection rate can be
best monitored, and values are normalized to the controls. Each condition is the mean of at least three independent experiments; standard errors are
indicated. (D) After cell surface binding, EGF-biotin coupled to streptavidin
AlexaFluor488 was endocytosed for 10 min or 50 min at 37uC in HeLa cells
treated siRNAs against SNX12. Cells were labeled with anti-EEA1 or Lamp1 antibodies and analyzed by triple channel fluorescence. (E) HeLa cells were
treated with siRNAs against SNX12 or mock treated and then incubated with EGF for the indicated time periods. Cell lysates (100 mg) were analyzed
by SDS gel electrophoresis and western blotting with antibodies against EGFR or a-tubulin (a-tub).
doi:10.1371/journal.pone.0038949.g003
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against anti-LBPA [37] and anti-VSV-G (17.2.21.4) were
described [38]. We also used polyclonal antibodies made in rabbit
against Rab6 (Santa Cruz Biotechnology) and made in sheep
against the EGFR (Fitzgerald). We are very grateful to Wanjin
Hong (Singapore. Singapore) for rabbit polyclonal antibody
against SNX3. HRP-labeled secondary antibodies were from
Amersham [39] or Sigma-Aldrich (St Louis, MO) and fluores-
cently labeled secondary antibodies from Jackson Immunore-
search Laboratories (West Grove, PA). Wortmannin, nocodazole,
EGF were from Sigma-Aldrich, EGF-biotin-streptavidin-Alexa
FluorH 488 complex and transferrin-Alexa FluorH 546 from
Invitrogen. We are very grateful to Ludger Johannes (Paris.
France) for supplying us with Cy3-labeled Shiga toxin B-subunit.
We obtained pGFP-Rab5
Q79L from Marino Zerial (Dresden.
Germany) and myc-tagged SNX3 from Carol R. Haft (National
Institutes of Health, Bethesda, Maryland).
Plasmids, RNA Interference and Transfection
Total RNA from HeLa cells was extracted with phenol-
chloroform and precipitated with isopropanol. Then, reverse
transcription was performed from 0.5 mg total RNA using
Superscript RT (Invitrogen) and random hexamers. Next, the
sequence encoding human SNX12 was amplified by PCR using
the following primers: 59-CCGGAATTCCGGATGTCGGA-
CACGGCAGTAGCTG-39 and 59-CGGGATCCGC-
TACTGGCGCACCTTCCCCGGGA-39 and introduced at
EcoRI/BamHI restriction sites into pEGFP-C2 vector (Clontech).
SNX12 was also fused with mRFP1 (pmRFP1) or double myc tag
(pDMyc). The PtdIns3P binding-defective mutant SNX12
R71A
was obtained by QuikChange Site-Directed Mutagenesis (Strata-
gene). The resulting plasmids were verified by DNA sequencing.
Cells were transfected with these different vectors using FU-
GENEH 6 Transfection Reagent (Roche Diagnostics Basel,
Switzerland) according to the manufacturer’s instructions. In
Figure 4. SNX12 overexpression induces an accumulation of MVB-like structures and rescues the intralumenal vesicles that
incorporate the EGF receptor. (A-B) HeLa cells expressing GFP-SNX12 were fixed and processed for electron microscopy. Cryosections were
labeled with antibodies against GFP followed by protein A-gold 10 nm (arrows). Panel A shows a cluster of several multivesicular endosomes, each
being labeled with a star, and panel B shows a high magnification view of an individual multivesicular endosome. Scale bar indicates 250 nm. (C) Hrs
(D-E) or SNX3 (F-G) was knocked down and mRFP-SNX12 (red) was overexpressed (E-G) or not (D-F). In each condition, HeLa cells were also
transfected with GFP-Rab5
Q79L (green) during the last 24 h. After cell surface binding, EGF was internalized for 15 min at 37uC. Cells were processed
for immunofluorescence with anti-EGFR antibodies (blue). The relative amount of EGFR in the lumen of endosome was quantified as previously
described [25]. Results are expressed as the percentage of the total amount of EGFR. Each condition is the mean of at least three independent
experiments; standard errors are indicated and results were analyzed by paired t test (***, p,0,001). (D-G) Representative pictures of experiments
quantified in (C). GFP-Rab5
Q79L enlarged endosomes in each condition showed the EGFR localization after Hrs (D-E) or SNX3 (F-G) was knocked
down and mRFP-SNX12 (red) was overexpressed (E-G) or not (D-F).
doi:10.1371/journal.pone.0038949.g004
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at a 24 h interval using LipofectamineTM RNAiMAX transfec-
tion Reagent (Invitrogen) with 21-nucleotide RNA duplexes
(Qiagen), replated 4 h after the second transfection, and analyzed
36 h later. For SNX12 silencing, we used the following target
SNX12 sequence: 59-AAGGGATCTTTGAGGAGTCTT-39.
Quantitative PCR
Total RNA from different cell types was extracted with RNeasy
(Qiagen), according to manufacturer’s instructions. Then, reverse
transcription was performed from 5 mg total RNA using Super-
script RT (Invitrogen) and Oligod(T) (Invitrogen). SNX3 and
SNX12 were amplified by quantitative real time-PCR using SYBR
Green (Roche). All real-time PCR reactions were performed on a
LC480 (Roche), with the following cycling parameters: annealing
and amplification at 60uC for 60 s, and dissociation at 95uC for
10 s. The PCR program was followed by a melting curve and
SNX12 values were normalized to the relative amounts of SNX3.
In vivo Endocytic Transport Assay
HeLa cells were incubated for 1 h at 4uC with 0.5 mg/mL EGF-
biotin-streptavidin-Alexa FluorH
488 complex, 1 mM Cy3-labeled
Shiga toxin B-subunit, or with 20 mg/mL transferrin-Alexa
FluorH
546. After washes, the marker was then endocytosed for
the indicated time periods at 37uC and cells were processed for
immunofluorescence. For EGFR degradation, cells were preincu-
bated in serum-free medium, and then incubated with 0.25 mg/
mL EGF and 10 mg/mL cycloheximide for the indicated time
periods. Cell lysates were analyzed by SDS gel electrophoresis and
western blotting with the indicated antibodies.
Immunofluorescence
Immunofluorescence microscopy has been previously described
[40]. Briefly, cells were fixed in 4% PFA for 20 min at room
temperature. They were then incubated with the primary antibody
in PBS containing 10% FCS and 0.05% saponin for 60 min
followed by the Cy2-, Cy3- or Cy5-conjugated fluorescent
secondary antibodies. Pictures were captured using a Zeiss LSM
510 META confocal microscope equipped with a 633 Plan-
Apochromat objective.
VSV Infection
The VSV infection was measured by monitoring the appear-
ance of the viral glycoprotein G in the host-cell biosynthetic
pathway as described [29]. Briefly, virus (1 MOI) was bound to the
plasma membrane on ice and then cells were incubated for 3 h at
37uC. Finally, G-protein appearance in biosynthetic membranes
was visualized by immunofluorescence using anti-VSV-G anti-
bodies.
Liposome Binding Assay
Lipids in chloroform were mixed in a pyrex test tube at the
given molar ratios and dried under Nitrogen. Liposome buffer
(50 mM Hepes-NaOH pH 7.2, 100 mM NaCl) was added to the
dried lipid mixture to a final 0.5 mg/mL lipid concentration, and
lipids were rehydrated for 1 h on ice in the dark. After sonication
in a bath-type sonicator for 265 min, the lipids were vortexed for
30 s. 50 mg liposomes were mixed with 10 mg protein in 200 mL
final volume and incubated for 2 h at 4uC with end-over-end
mixing in the dark. Then, the mixture was adjusted to 40.6%
sucrose, loaded at the bottom of a TLS-55 centrifuge tube,
overlaid sequentially with 35 and 8.5% sucrose solutions in 3 mM
imidazole, pH 7.4, and centrifuged in a TLS-55 rotor at 55000
rpm for 1 h at 4uC [41]. The 8.5/35% interphase that contains
liposomes, the 35% fraction, as well as the 40.5% fraction that
contains the free proteins were collected. Half of the collected
samples was analyzed by immunoblotting.
GST Pull-down
Culture dishes (10 cm) with confluent HeLa cells were washed
twice with ice-cold PBS on ice and scraped in lysis buffer
containing 20 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA,
10% glycerol, 1% digitonin (w/v) and protease inhibitors. After
30 min incubation at 4uC, cell lysates were cleared by centrifu-
gation at 13,000 g for 20 min at 4uC, and then incubated with
25 mg GSTtagged protein overnight at 4uC with end-over-end
mixing. The mixture was added to 100 mL glutathione Sepharose
beads and incubated 1 h at 4uC with end-over-end mixing. Beads
were spun down at 3000 rpm, 3 min at 4uC and then washed 66
in detergent-free lysis buffer. Proteins were eluted from the beads
by boiling in sample buffer with b-mercaptoethanol and followed
by SDS-gel electrophoresis and western blotting.
Supporting Information
Figure S1 EGFR and Shiga toxin B-subunit transport in
control cells. (A-C) After cell surface binding, EGF-biotin
coupled to streptavidin
AlexaFluor488 was endocytosed for 10 min (A)
or 50 min (B-C)a t3 7 uC, as in Fig1 but in untransfected HeLa
cells. Cells were labeled with anti-EEA1 (A-B) or Lamp1 (C)
antibodies and analyzed by immunofluorescence. (D) After cell
surface binding, Shiga toxin B-subunit conjugated to Cy3 was
internalized for 50 min at 37uC, as in Fig1 but in untransfected
HeLa cells. Cells were labeled with Rab6 antibodies and analyzed
by immunofluorescence. Bar: 10 mm.
(PDF)
Figure S2 SNX12 distribution depends on the binding to
PtdIns3P. (A) HeLa cells expressing GFP-SNX12 or the 3-
phosphoinositide binding defective mutant GFP-SNX12
R71A were
treated or not with 100 nM wortmannin for 30 min at 37uC and
then analyzed by immunofluorescence microscopy. Bar: 10 mm.
(B) Purified recombinant wild type SNX12 (SNX12 WT) and
SNX12
R71A mutant were analyzed by SDS gel electrophoresis and
visualized after Coomassie blue staining. (C) Wild type SNX12 or
SNX12
R71A were incubated with liposomes containing PtdIns3P
or PtdIns. Liposomes were then separated from unbound protein
by floatation in a step sucrose gradient. 110 mL from each fraction
were collected and 50 mL of them were run on 12% SDS gel and
further analyzed by immunoblotting. (D) HeLa cells were
transfected with GFP-SNX12
R71A mutant or mock-treated and
then incubated with EGF for the indicated time periods. Cell
lysates (100 mg) were analyzed by SDS gel electrophoresis and
western blotting with antibodies against EGFR or GFP.
(PDF)
Figure S3 SNX12 interacts with the retromer. (A) HeLa
cells expressing mRFP1-SNX12 were processed for immunofluo-
rescence using the indicated antibodies. Scale bar indicates 10 mm.
(B) Recombinant GST-SNX1, GST-SNX3 and GST-SNX12
were produced, analyzed by SDS gel electrophoresis and
visualized after Coomassie blue staining. (C) Recombinant
proteins visualized in (B) were incubated with cell lysates (input),
then retrieved using glutathione Sepharose beads and analyzed by
SDS gel electrophoresis and western blotting with antibodies
against Vps35. Ponceau staining showed the recombinant proteins
precipitated after pull down.
(PDF)
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